- RESEARCH USE ONLY
- INDEPENDENTLY THIRD-PARTY TESTED
- COA EVERY LOT
- US-BASED OPERATIONS
| Specification | Details |
|---|---|
| Compound | AOD-9604 |
| Type | Synthetic peptide |
| Sequence | YLRIVQCRSVEGSCGF |
| Quantity | 5 mg |
| Purity | ≥99% HPLC Certified |
| Molecular Formula | C₇₈H₁₂₃N₂₃O₂₃S₂ |
| Molecular Weight | 1815.1 g/mol |
| CAS Number | 221231-10-3 |
| Form | Lyophilized powder |
| Appearance | White to off-white powder |
| Solubility | Soluble in laboratory-grade sterile water |
| Documentation | COA included in product image gallery |
$59.99
For Research Use Only | Not for Human or Veterinary Use
AOD-9604 is a synthetic 16-amino-acid peptide derived from a defined fragment of human growth hormone. It has been studied in laboratory and research settings in connection with peptide structure, metabolic signaling, and related biological activity. AOD-9604 contains a disulfide bridge between two cysteine residues, giving it a defined cyclic structure.
This material is supplied as a lyophilized powder for laboratory research, analytical testing, and related scientific applications.
The sequence, molecular formula, molecular weight, and CAS number correspond to the AOD-9604 record in PubChem. The molecule contains two cysteine residues connected by an intramolecular disulfide bond.
AOD-9604 is a 16-residue peptide associated with the 177–191 region of human growth hormone, with an additional N-terminal tyrosine. Its sequence is YLRIVQCRSVEGSCGF, with the cysteine residues forming a 7–14 disulfide bridge.
Early research investigated AOD-9604 in metabolic and obesity-related research programs. Published literature includes discussion of its development and experimental investigation, while later regulatory review has noted that available safety information for human administration remains limited.
For laboratory work, the structural identity of the peptide is particularly relevant because the disulfide bond and defined sequence distinguish AOD-9604 from other growth-hormone-derived peptide fragments.
A Certificate of Analysis (COA) is included in the product image gallery for laboratory reference. The listed purity specification is based on HPLC analysis as supplied with this research material.
Researchers should review the batch-specific documentation before using the material in analytical or experimental workflows.
AOD-9604 remains a research compound rather than an FDA-approved therapeutic product. In its review of nominated bulk drug substances, the FDA has identified limited safety information and potential concerns involving immunogenicity, peptide-related impurities, and active pharmaceutical ingredient characterization.
AOD-9604 is also listed by the World Anti-Doping Agency (WADA) under S2.3 Growth Hormone, its fragments and releasing factors as a prohibited growth hormone fragment.
AOD-9604 contains 16 amino acids. Its sequence is YLRIVQCRSVEGSCGF, with two cysteine residues forming an internal disulfide bond.
The molecular weight listed by PubChem for AOD-9604 is approximately 1815.1 g/mol. This value corresponds to the disulfide-bridged molecular structure.
The CAS Registry Number associated with AOD-9604 is 221231-10-3. PubChem also identifies the compound under PubChem CID 71300630.
The two sulfur atoms come from its two cysteine residues. These residues form an intramolecular disulfide bridge between positions 7 and 14, contributing to the peptide's defined cyclic structure.
No. AOD-9604 is a 16-residue synthetic peptide derived from a specific growth-hormone fragment, rather than the complete human growth hormone protein. Its sequence and molecular structure are separately defined.
Yes. WADA lists AOD-9604 among growth hormone fragments under the prohibited S2 category. The prohibition applies at all times under the applicable Prohibited List.
AOD-9604 is supplied for laboratory research and analytical applications with batch documentation available through the product gallery.
For Research Use Only | Not for Human or Veterinary Use
